< 10%) and 65 per cent in patients who were not in shock (predicted < 50%). Survival at 4 years was 10 ± 4 per cent in shock and 37 ± 11 per cent in patients not in shock; functional status was class 1 or 2 in 5 of 9 patients in shock and in 8 of 12 survivors not in shock. Results were best when counterpulsation was started early after onset of symptoms, when ischaemic pain was still present, or when a mechanical defect was corrected surgically. Early coronary artery bypass surgery performed alone in 9 patients did not influence survival or functional status. Complications of counterpulsation occurred in 17 patients in shock and in 2 patients not in shock, all but 6 on the first day; none directly caused death. Counterpulsation is an effective and safe adjunct to medical treatment of complicated infarction provided the intervention is prompt.
Ten years after the first application of intra-aortic balloon counterpulsation in man (Kantrowitz et al., 1969) there is still no consensus as to its role in the management of acute myocardial infarction. Physiological principles concerning the left ventricle's demand for and supply of blood (Sarnoff et al., 1958; Berne, 1964) strongly suggest that such a role exists, as do experimental findings in animals with myocardial ischaemia and early infarction (Soroff et al., 1963; Brown et al., 1967; Goldfarb et al., 1968; Powell et al., 1970; Maroko et al., 1972) . However, in the 2 clinical syndromes of acute coronary disease with which most experience has been obtained-cardiogenic shock on the one hand and coronary insufficiency on the other-many published results show little benefit over conventional therapy (Scheidt et al., 1973; Forrester et al., 1976; Mundth, 1976) . Furthermore, where benefit has been evident, counterpulsation has often been combined with coronary artery bypass surgery so that its own role has remained uncertain (Dunkman et al., 1972; Sanders et al., 1972; Leinbach et al., 1973; MiUer et al., 1974; WiUerson et al., 1975; Bardet et al., 1977; Erich et al., 1977) .
We report here our experience with the first 100
Received for publication 9 May 1978 patients with acute infarction who were treated with counterpulsation over a 5-year period. These patients were accepted from a group of over 300 referred for consideration of mechanical heart assistance (O'Rourke et al., 1975 (O'Rourke et al., , 1976 .
Criteria and procedure
In the first 8 months of this project (November 1971 to July 1972), we followed strictly the procedure adopted at the Massachusetts General Hospital (Dunkman et al., 1972; Sanders et al., 1972) ; we reserved counterpulsation for patients who met the strict MIRU criteria of cardiogenic shock (Dunkman et a!., 1972) and subjected all patients on counterpulsation to coronary angiography within the first 48 hours with a view to early coronary artery bypass surgery. Results at this stage were dismal (O'Rourke et al., 1975) . We attributed these poor results to the unrealistically strict definition of shock, to the delays incurred in preliminary assessment, and to the trauma of cardiac diagnostic and surgical procedures.
We, therefore, developed a different procedure which we have followed strictly over the latter part of this project. Our present procedure requires (1) a diagnosis of definite acute myocardial infarction by WHO criteria (WHO, 1970) , (2) definite evidence of acute severe heart failure by clinical and radiological criteria (WHO, 1970) , or (if such signs are equivocal) an increase in pulmonary artery pressure above 16 mmHg wedge or 20 mmHg mean, and (3) absent or completely unsatisfactory response to medical treatment over at least a 2-hour period, such treatment to include oxygen by mask, relief of pain, adequate diuretics (the minimum dose of frusemide was 80 mg by intravenous injection), and correction of haemodynamically significant arrhythmias. The MIRU definition of cardiogenic shock (Dunkman et al., 1972; Sanders et al., 1972; O'Rourke et al., 1975) was modified by (a) foregoing the requirement of pulmonary and systemic catheterisation before counterpulsation if clinical signs of cardiac failure were unequivocal and if indirect pressure in the brachial artery was less than 100 mmHg systolic and (b) allowing urine output up to 25 ml/hour with diuretic therapy. All other aspects of the 'MIRU definition' (Dunkman et al., 1972) were retained.
Our present procedure requires that diagnostic cardiac catheterisation and coronary angiography be performed only if (1) a mechanical complication is suspected, (2) a patient cannot be weaned from counterpulsation after 2 weeks, or (3) angina pectoris recurs after counterpulsation is terminated. The procedure no longer includes consideration of early coronary artery bypass surgery. The procedure requires that counterpulsation be continued until maximal clinical improvement has been attained and maintained for at least 3 days. At this stage (usually after 7 to 10 days), a trial of weaning is performed (O'Rourke et al., 1975) . If deterioration occurs, counterpulsation is continued for a further 4 to 7 days and the trial repeated. If no deterioration occurs, the balloon catheter is removed.
Avco catheters and consoles were used throughout. The balloon catheter was inserted through a 'dacron' side graft into the femoral artery (Kantrowitz et al., 1968) . Monitoring catheters were placed in the pulmonary and brachial or radial artery of all patients. In the interests of expediency this procedure was usually done at the same time as the surgical team was cannulating the femoral artery. Heparin (usually 5000 international units intravenously, 4 hourly) was administered to all patients except those undergoing cardiac surgery; and these were given low molecular weight dextran (10 mJ/hour) during operation instead. Cephalothin (0 5 g intravenously, 6 hourly) was administered routinely. Drug treatment for heart failure was continued but adjusted when improvement occurred.
In this study, contraindications to counterpulsation were similar to those applied by others 309 (Dunkman et al., 1972; Sanders et al., 1972) Predicted survival rate for patients with shock was < 10 per cent (Wan et al., 1971; O'Rourke et al., 1975; O'Rourke, 1977) and for patients without shock was < 50 per cent from Peel et al. (1962) and Norris et al. (1969) indices (Table 2 ). Of the first 200 patients referred to us for consideration of counterpulsation, 39 met the criteria but did not proceed to counterpulsation. Of these, only 2 (5%) (including 1 patient who was not in shock) were hospital survivors.
Results (a) PATIENTS IN CARDIOGENIC SHOCK
Initiation of counterpulsation was associated with clinical improvement in the majority of patients. Relief was manifest in reduction of mean pullmonary artery pressure and heart rate from 34 ± 10 mmHg and 110 + 22/min to 26 ± 10 mmHg and 98 + 17/min, respectively, by the end of the first day (P < 0-001 for each by paired t test). Deterioration during counterpulsation was seen only in patients who remained in shock or acute renal failure despite counterpulsation and in those undergoing early trials of weaning, angiography, and cardiac surgery. Deterioration after termination of counterpulsation was, however, common. (Fig. 1) ; there was no indication from these mortality figures of secondary deterioration after the first 24 hours of counterpulsation.
Of the 74 patients, 29 underwent cardioangiography during the period of circulatory assistance; 18 underwent cardiac surgery as a consequence. Six had early aortocoronary bypass surgery only, while 11 had correction of a mechanical defect with or without coronary bypass as well (Table 1) . Corrective procedures were: closure of septal defect (6), mitral valve replacement (2), excision of aneurysm (1), infarctectomy with pericardial drainage (1), and pericardial drainage alone (1).
Early coronary artery bypass graft surgery did not confer any benefit. Of the 6 patients so treated, 4 died in hospital. Correction of a mechanical defect on the other hand often had dramatic consequences. The 2 patients with haemopericardium treated by open drainage improved greatly though 1 who remained in shock required a further period of counterpulsation after operation before satisfactory renal function returned. Both left hospital in good condition as did the patient whose aneurysm was excised. Neither patient with ruptured papillary muscle and only one with septal defect left hospital; this patient, however, made a complete recovery. The experience with ruptured septum and papillary muscle was disappointing, with only 1 survivor in 10 treated. This may have been because of the late I 311 intervention with surgical repair performed 20 to 220 (mean 65) hours after the onset of shock and 8 to 216 (mean 48) hours after initiation of counterpulsation. The mitral valve repair remained intact in both cases undergoing valve replacement, but in 3 of the 6 patients undergoing repair of septal defect (including the survivor) the repair subsequently broke down. The survivor had a further patch inserted 12 weeks after the first operation. Twenty-five patients left hospital-21 who had no mechanical defect and 4 who did. Sixteen patients died in the follow up period-14 from severe heart failure, 1 from reinfarction, and 1 from cancer. Both patients who underwent early coronary artery bypass grafting alone died in the follow up period. Long-term results were poor (Fig. 2) , with only 10 per cent survival at 4 years. Long-term results were dismal in patients without mechanical complications, whose survival rate was 6 per cent at 4 years (there being only 6 of 58 alive at the time of follow up) (Fig. 3 ). Results were better in patients who underwent correction of a mechanical defect with only 1 late death (from cancer) in 4 hospital survivors. Survivor status was also better in the patients with corrected mechanical defects, all having returned to work or previous activities and all being in New York Heart Association functional class 1 or 2. In contrast, only 2 of the 6 living patients who had no mechanical complication were in functional class 1 or 2.
Late survival and survivor status was related to the delay in initiating counterpulsation after the EarlyC'P n=20 SD= 18I. All patients showed improvement with initiation of counterpulsation. The most dramatic effect was on ischaemic heart pain which was present in 12 patients; pain was abolished within minutes in 11 patients and within 12 hours in the other. Symptomatic improvement from left ventricular failure was usually manifest within 2 hours, with radiological clearing of pulmonary oedema usually occurring by the third day of counterpulsation. Pulmonary artery pressure fell from 32 ± 8 mmHg before counterpulsation to 19 ± 6 mmHg (P < 0-001) by the end of the first day, and heart rate from 118 ± 16 beats/minute to 104 ± 17 beats/minute (P < 0-001) by the end of the first day. Eleven patients had conduction disturbances before counterpulsation; normal conduction was established within 48 hours in8.
Recurrent ventricular arrhythmias became less frequent with initiation of counterpulsation in the 8 patients so affected. Counterpulsation was continued for 1 to 15 (mean 7 9) days. When counterpulsation was stopped there was little alteration in heart rate or in pulmonary or systemic pressure in the whole group, though in some patients there were signs of deterioration.
Nine patients died in hospital (mortality rate 35%). Six deaths were attributable to heart failure and 3 to primary ventricular fibrillation during hospital convalescence. One patient died during the period of counterpulsation and 8 after this had been terminated. Results were poor in patients treated more than 1 week after the onset of infarction; all but one (with pseudoaneurysm) died in hospital of heart failure. Results were good in patients whose heart failure was associated with continuing ischaemic pain; there was only 1 hospital death in 12 such patients. Four patients underwent coronary artery bypass surgery, 3 in the acute stage and 1 6 weeks after termination of counterpulsation. Of the 3 patients undergoing early coronary artery bypass, 2 died in hospital.
Of the 17 hospital survivors, 5 died during the follow up period. Survival at 4 years was 37 per cent L - (Fig. 2) (Table 4) reported by others who have attributed results to unterpulsation were usually early coronary bypass surgery (Dunkman et al., ually occurred in poor risk 1972; Sanders et al., 1972; Leinbach et al., 1973;  )mplications, 13 occurred on Miller et al., 1974; Willerson et al., 1975; Bardet quently during counterpulsa-et al., 1977; Erich et al., 1977) . Our results were no Loval of the balloon catheter better in patients undergoing bypass surgery than , complications after discharge in those treated with counterpulsation alone. These 19 complications, 17 occurred findings were welcome because we had found early vogenic shock, and only 2 in angiographic assessment and surgery a complex
No patient died as a direct undertaking, tiring to the patient, logistically :ion.
difficult, disruptive of routine work, and demoralisperfusion of the leg-pallor, ing to staff when unsuccessful. The findings were )ulses-were often seen with-not unexpected because we could not understand ,ertion of the balloon catheter how bypass surgery performed 48 hours and more ry. Such signs were usually after the onset of symptoms could influence the was frequently found in the progression of ischaemia to infarction-a process which in most cases appears to be complete within the first 24 to 48 hours of the onset of symptoms of counterpulsation (Sobel et al., 1972; Braunwald, 1974; rene) 10 1975). Proponents of early surgical revascularisation 3 have cited 'balloon dependence' (Dunkman et al., counterpulsation alone. We found that patients who were 'balloon dependent' at 1 or 2 days were usually ons of counterpulsation not so at 7 or 14 days. We have rarely seen secondary deterioration during counterpulsation, the usual finding (reflected in haemodynamic patterns and M Complications mortality rates (Fig. 1) ) being continued improverJ No complication ment with the passage of time. Where reported (Dilley et al., 1973; Erich et al., 1977) , secondary deterioration may have been the result of angiographic investigation and trials of weaning. We attributed the gradual improvement with time to gradual recovery of reversibly damaged myocardium (Heyndrickx et al., 1975) and development of collaterals.
Gradual improvement in cardiac performance _ _ I I lover several days after infarction has been docu-10 15 27 30 mented (Russell et al., 1970) . It is interesting that the average duration of counterpulsation in this ulsation complications in all series (7-0 days) was similar to the average duration of vasodilator therapy chosen by Chatterjee et al. (1976) (7-6 days) on the basis of stabilisation of haemodynamics and clinical improvement. Despite the improved early results in patients with cardiogenic shock caused by myocardial power failure the general outlook is still poor with high morbidity and mortality in the ensuing years from chronic cardiac failure. These results have been obtained however in a group of patients who underwent counterpulsation more than 24 hours on average after the onset of symptoms when signs of massive irreparable myocardial damage were already apparent. Results were far better in patients treated early. It is probably unrealistic to expect better results in patients treated as late as those described here.
Results in patients with mechanical defects were similar to those reported elsewhere Leinbach et al., 1973; Bardet et al., 1977) . We believe that results would have been even better still had we proceeded expeditiously to counterpulsation, angiography, and surgical correction. Five patients in this series had subacute rupture of the heart (O'Rourke, 1973) with haemopericardium; in 2 cases this was associated with septal rupture. After septal rupture, subacute heart rupture was the most common mechanical complication encountered. Surprisingly there is no mention of this complication in other published series except as a cause of death in patients treated with cardiogenic shock (Kantrowitz et al., 1969; Bardet et al., 1977) . Subacute heart rupture proved difficult to diagnose (and was missed completely in 2 patients even at diagnostic angiography), but we believe it should be strongly suspected in patients with late onset of cardiogenic shock (more than 24 hours after onset of symptoms), especially when signs of right heart failure are dominant (O'Rourke, 1973) even in the absence of classical features of tamponade. Our present procedure is to proceed promptly to cardiac surgery in patients with echocardiographic and clinical evidence of tamponade.
Use of counterpulsation in patients with refractory heart failure but without shock was a logical extension of our experience in cardiogenic shock and represented an attempt to prevent shock. After patients with cardiogenic shock, this group has the highest mortality of any occurring after infarction. Surprisingly, only2 similar series have been reported before (Willerson et al., 1975; Hagemeijer et al., 1977) . In the absence of controls it is not possible to be sure how these patients would have fared without counterpulsation. An attempt was made to estimate hospital survival from prognostic indices of Peel et al. (1962) and Norris et al. (1969) . In using these indices it must be conceded that they were developed before the advent of coronary care wards and may overestimate mortality. Against this however coronary care has not led to improved survival in patients with severe heart failure (Meltzer and Kitchell, 1972) , and, further, the indices were applied by us to patients after conventional treatment had failed rather than before any treatment had been started. It is, therefore, probable that mortality was reduced by counterpulsation.
As in patients with cardiogenic shock, patients without shock did not benefit from early coronary artery bypass surgery. In addition, results were poor in patients undergoing counterpulsation late after the onset of symptoms (unless a mechanical defect was present) and good in patients treated early especially if there was evidence of continuing ischaemia. These findings are easily explicable on the basis of counterpulsation causing relief of myocardial ischaemia and reduction in infarct size (Mueller et al., 1971; Braunwald, 1974) .
After surgical revascularisation, counterpulsation is probably the most powerful method currently known for relieving myocardial ischaemia (Mueller et al., 1971; Braunwald, 1974 (Page et al., 1971) but it makes little sense to aim at redressing only the secondary effects of shock. The approach to counterpulsation in patients with infarction has been ultraconservative as though the procedure itself carries little chance of benefit and great risk of harm. Chance of benefit indeed appears to be great (provided counterpulsation is initiated early) and the risk of complication quite low. In our hands complications have been infrequent and have posed Jittle risk of life and limb. Contrary to other views (Pace et al., 1976) we believe that the complications are largely those of the insertion procedure in a desperately ill patient. Once counterpulsation is established and the patient responding, the chance of late complication is remote and very low indeed when judged against the chance of clinical improvement. Risk of late complications we believe should not dictate early termination of counterpulsation within 1 to 2 weeks in a patient who is responding weil.
There has been increasing use of counterpulsation in coronary insufficiency or threatening infarction (Mundth, 1976) . That counterpulsation has established a role in this low risk condition testifies to the safety of the procedure itself.
We have sought no experience in this area, being currently satisfied with conventional treatment: over the past 5 years we have had 7 9 per cent infarction rate with 541 per cent mortality rate in 79 patients with coronary insufficiency, refractory to medical therapy, who underwent aortocoronary bypass surgery. Happy as we are with the relative safety of counterpulsation in poor risk patients, we have reservations about the risk against possible benefit in patients with coronary insufficiency.
To date clinical experience with counterpulsation in myocardial infarction has been confined almost exclusively to 2 extremes of the clinical spectrumfrom threatening infarction on the one hand to cardiogenic shock on the other: from a condition with around 5 per cent mortality risk on conventional treatment on the one hand to 95 per cent on the other. Evidence of clinical benefit in the two groups of patients suggests a role throughout the spectrum. The data presented in this paper support such a concept: that counterpulsation may have an important place by itself in treatment of acute infarction, provided intervention is prompt. We are currently investigating this with a randomised controlled trial.
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